Defining sacroiliac pain
The sacroiliac joint complex (SIJC) is a diarthrodial, synovial joint with an associated posterior ligamentous network that can be a significant source of chronic low back pain. Nociception arising from the SIJC has been estimated to account for a substantial proportion of chronic low back pain presentations, and the joint receives both anterior innervation from the lumbosacral plexus and posterior sensory innervation via the posterior sacral network (PSN). This dual innervation underpins the clinical heterogeneity of sacroiliac pain and informs both diagnostic and interventional strategies.
The posterior innervation of the sacroiliac region is mediated primarily by the posterior sacral network, a plexus formed by the lateral branches of S1–S3 posterior rami, with variable contributions from S4 and the L5 dorsal ramus. After exiting the posterior sacral foramina, these lateral branches converge along the lateral sacral crest, typically extending from the second to just below the third transverse sacral tubercle. This anatomical arrangement is clinically relevant because it defines the target zone for both diagnostic lateral branch blocks and radiofrequency ablation (RFA) of the PSN.
Clinically, sacroiliac pain is characterized by low back or buttock pain often localized below the L5 level and may be reproduced by specific provocative maneuvers. A best-practice summary for radiofrequency neurotomy describes the diagnostic process as including multiple provocation tests such as distraction, side thigh thrust, Gaenslen, compression, and sacral thrust. The predictive value for sacroiliac pathology is greatest when at least two of four selected tests are positive, whereas the absence of pain reproduction with all six commonly used maneuvers makes sacroiliac pathology unlikely.
Despite the utility of physical examination, no single provocation maneuver is pathognomonic for sacroiliac pain, and clinical findings alone lack sufficient sensitivity and specificity. As a result, image-guided diagnostic blocks of the sacroiliac joint or its posterior innervation have become standard adjuncts to refine diagnosis and guide interventional management. In this context, sacroiliac pain is best defined as pain arising from the sacroiliac joint complex that is supported by a compatible clinical presentation, positive provocation testing, and confirmatory response to appropriately performed diagnostic blocks.
Diagnostic blocks and clinical indicators
Appropriate patient selection for sacroiliac RFA relies heavily on diagnostic blocks targeting either the intra-articular joint space or the posterior sacral lateral branches. A narrative review of sacroiliac diagnostic block and RFA techniques emphasizes that diagnostic blocks of the SIJ posterior innervation are the recommended method for identifying candidates for sacral lateral branch RFA. These blocks aim to anesthetize the PSN along the lateral sacral crest, thereby reproducing the distribution of analgesia expected from subsequent neurotomy.
Multi-site, multi-depth sacral lateral branch blocks have been shown to effectively anesthetize the sacroiliac joint complex, including the posterior joint and associated ligaments. This approach is technically more demanding but is considered more anatomically comprehensive than single-site injections. A randomized comparison of ultrasound-guided lateral branch blocks at the lateral crest versus fluoroscopy-guided multi-site, multi-depth blocks (including L5 dorsal ramus) demonstrated comparable anesthetization of pain-generating SIJ structures, suggesting that a well-executed lateral crest technique can be sufficient without routine L5 dorsal ramus inclusion.
Best-practice recommendations for lateral sacral branch RFA highlight that a diagnostic block for the lateral sacral branches is highly recommended prior to neurotomy, even when a prior intra-articular sacroiliac injection has been performed. While the evidence base for an exact cutoff is limited, a reduction in pain of 50% or greater following diagnostic block is recommended before proceeding to RFA. Multisite and multi-depth techniques are advised to ensure adequate coverage of the PSN and to improve the prognostic value of the block.
The COBRA-SIJ protocol incorporates both prognostic PSN blocks and diagnostic intra-articular sacroiliac injections into its eligibility criteria. Participants must demonstrate at least 50% pain relief from either a combination of fluoroscopically guided intra-articular SIJ injection plus PSN block, or from dual PSN blocks alone, to qualify for RFA. Pain relief is documented using a structured pain diary with categorical levels of relief, and the treating physician uses this information to determine eligibility. This protocolized use of diagnostic blocks exemplifies how clinical indicators and block response are integrated to select patients most likely to benefit from sacroiliac RFA.
Inclusion and exclusion criteria (COBRA-SIJ)
The COBRA-SIJ study is a double-blind randomized controlled trial comparing conventional monopolar periforaminal RFA with a bipolar “palisade” strip lesion technique for treatment of sacroiliac joint complex pain. Its inclusion and exclusion criteria provide a structured framework for patient selection that can inform clinical practice. Participants are adults aged 18–90 years with at least three months of low back pain attributable to the sacroiliac joint complex who have not responded to at least three months of conservative treatment. A baseline 7‑day average numeric pain rating scale (NPRS) score of at least 4/10 is required, ensuring a minimum threshold of symptom severity.
A key inclusion criterion is a robust response to diagnostic interventions. Eligible participants must have pain relieved by at least 50% following either both a fluoroscopically guided intra-articular sacroiliac joint injection with local anesthetic and a fluoroscopically guided PSN block, or following dual fluoroscopically guided PSN blocks. This dual-pathway approach acknowledges that both intra-articular and posterior innervation–targeted blocks can confirm sacroiliac origin of pain, while emphasizing a consistent quantitative threshold of analgesic response.
The exclusion criteria in COBRA-SIJ are designed to minimize confounding pain generators and procedural risk. Patients with a history of sacroiliac joint fusion or prior sacroiliac RFA are excluded, as are those with symptomatic hip osteoarthritis or active lumbar radicular pain, which could obscure attribution of symptoms to the sacroiliac joint complex. Additional exclusions include evidence of hardware loosening in individuals with prior lumbar or lumbosacral fusion, presence of pacemaker or neurostimulator, chronic widespread pain or somatoform disorders such as fibromyalgia, daily opioid use exceeding 50 mg morphine-equivalent, and recent or active infection requiring antibiotics.
These criteria collectively define a population with localized sacroiliac joint complex pain, adequate symptom burden, and a clear diagnostic response to targeted blocks, while excluding patients with competing pain sources, systemic pain syndromes, or significant medical contraindications. In clinical practice, adopting similar inclusion and exclusion parameters can help align patient selection with the evidence base underlying sacroiliac RFA, particularly when using techniques analogous to those evaluated in COBRA-SIJ.
Role of imaging and functional tests
Imaging plays an important adjunctive role in the evaluation of sacroiliac pain and in patient selection for RFA, primarily to exclude alternative or coexisting pathologies. Best-practice guidance for lateral sacral branch neurotomy recommends that other potential etiologies of pain be ruled out by imaging before proceeding to RFA of the lateral sacral nerves. Radiographs may demonstrate degenerative changes or inflammation within the sacroiliac joint, but they are not considered diagnostic for sacroiliac pain. Thus, imaging is used more to identify contraindications or competing diagnoses than to confirm sacroiliac pain per se.
Within the COBRA-SIJ protocol, attribution of low back pain to the sacroiliac joint complex is based on a combination of physical examination, imaging, and response to prognostic PSN or diagnostic intra-articular blocks. Imaging contributes by documenting structural changes, prior instrumentation, or hardware status, and by helping to identify exclusionary conditions such as hardware loosening after lumbar or lumbosacral fusion. This integrated approach underscores that imaging findings must be interpreted in the context of clinical and block-based data.
Functional assessment tools are also embedded in the evaluation and follow-up of patients undergoing sacroiliac RFA. In the COBRA-SIJ study, outcomes include pain intensity measured by the numeric pain rating scale, disability assessed by the Oswestry Disability Index, health-related quality of life via the EuroQol-5D, and global improvement using the Patient Global Impression of Change. These instruments provide quantitative measures of pain and function that can be used both to characterize baseline impairment and to evaluate treatment response over time.
Additional functional and symptom-specific measures, such as the Pain and Sleep Questionnaire (PSQ-3), are used in COBRA-SIJ to assess the impact of sacroiliac RFA on pain-related sleep disturbance. In other interventional spine pain settings, composite questionnaires and pain-disability quality-of-life instruments have been validated for monitoring outcomes, and similar tools have been applied in sacroiliac RFA cohorts. Together, imaging and functional tests support a comprehensive assessment that informs both candidacy for RFA and subsequent evaluation of its clinical effectiveness.
Prognostic indicators for RF success
The literature on sacroiliac RFA highlights several factors that appear to influence the likelihood of achieving meaningful pain relief. A systematic review cited in the COBRA-SIJ background reports that 32–89% of patients achieve at least 50% pain relief for six months after PSN ablation, while 11–44% achieve complete relief over the same period. Outcome variability is attributed in part to heterogeneity in patient selection and RFA techniques. This underscores the importance of standardized diagnostic criteria and procedural methods when attempting to identify prognostic indicators for RFA success.
Response to diagnostic blocks is a central prognostic factor. The COBRA-SIJ protocol requires at least 50% pain relief following either combined intra-articular SIJ injection and PSN block or dual PSN blocks as a prerequisite for RFA. Best-practice recommendations for lateral sacral branch neurotomy similarly advise a threshold of 50% or greater pain reduction after diagnostic lateral branch blocks before proceeding to RFA. Studies summarized in evidence-based reviews often use higher cutoffs (for example, at least 75% relief with two sacroiliac joint blocks) as inclusion criteria, and report higher proportions of patients achieving at least 50% pain reduction at follow-up when such stringent block responses are required.
The choice of RFA technique and the extent of neural capture also have prognostic implications. Cadaveric work referenced in the COBRA-SIJ protocol suggests that bipolar strip lesions along the lateral sacral crest achieve substantially higher rates of PSN capture than conventional monopolar periforaminal lesions, with complete neural capture for periforaminal monopolar RFA reported as low as 12.5%. Clinical studies have shown that technologies capable of generating larger lesions, such as cooled or bipolar RFA, are associated with higher probabilities of treatment success compared with smaller conventional monopolar lesions. These findings imply that lesion size and continuity along the periosteum are important procedural determinants of outcome.
Patient-level characteristics may also influence prognosis, although detailed predictors are less consistently reported. A narrative review of sacroiliac RFA notes that chronic widespread pain syndromes and high-dose opioid use are potential negative prognostic factors, and these conditions are excluded in the COBRA-SIJ trial design. Furthermore, the requirement for failure of at least three months of conservative therapy before RFA ensures that candidates have persistent, treatment-refractory sacroiliac pain, which may enrich for individuals more likely to demonstrate measurable benefit from neurotomy. Collectively, robust block response, anatomically comprehensive lesioning, and careful exclusion of competing pain generators and systemic pain conditions emerge as key prognostic indicators for sacroiliac RFA success.
Clinical decision-making in SIJ RF
Clinical decision-making for sacroiliac RFA integrates anatomical understanding, diagnostic testing, and structured eligibility criteria. The posterior sacral network, formed by the lateral branches of S1–S3 with contributions from L5 and S4, is the principal target for lateral sacral branch neurotomy. Recognition that these branches travel along the periosteum at the lateral sacral crest informs both diagnostic block placement and RFA lesioning strategies, emphasizing the need for lesions that extend from the second to below the third transverse sacral tubercle to capture the majority of posterior innervation.
From a diagnostic standpoint, clinicians first establish a clinical suspicion of sacroiliac pain based on history and physical examination, including multiple provocation maneuvers. Imaging is then used to exclude alternative structural causes and to identify potential contraindications, such as sacral fracture, tumor, or hardware complications. When the clinical picture remains consistent with sacroiliac joint complex pain, image-guided diagnostic blocks—either intra-articular, lateral branch, or both—are performed to confirm the sacroiliac origin of pain and to prognosticate response to RFA.
The COBRA-SIJ protocol exemplifies a structured decision pathway: adults with chronic low back pain attributed to the sacroiliac joint complex, who have failed conservative therapy and demonstrate at least 50% pain relief with appropriately performed diagnostic blocks, are considered candidates for PSN RFA. Exclusion of patients with prior sacroiliac fusion or RFA, symptomatic hip osteoarthritis, active radiculopathy, chronic widespread pain, high-dose opioid use, or recent infection further refines the candidate pool. This approach aims to reduce confounding and optimize the causal attribution of outcomes to the RFA intervention.
Once a decision to proceed with RFA is made, the choice of technique—conventional monopolar periforaminal versus bipolar or cooled strip lesions—is informed by anatomical and cadaveric data suggesting superior neural capture with larger, continuous lesions. Best-practice recommendations support the use of bipolar or cooled RFA to ensure that the lateral branches are captured with a larger lesion, while acknowledging that monopolar RFA can be effective when multiple passes or periforaminal techniques are used to increase lesion size. Throughout this process, standardized outcome measures for pain, function, quality of life, and sleep are used to monitor response and to guide decisions about repeat interventions or alternative therapies.
Sources (Bibliography)
- Conger A, McCormick Z, Kendall R, Wagner G, Burnham T. Conventional or Bipolar Radiofrequency Ablation for the Treatment of Sacroiliac Joint Pain? The COBRA-SIJ study, a Double-blind, Randomized, Comparative Trial. Protocol Version 3.0, 2023.
- Stratus UofU Conger. Conventional or Bipolar Radiofrequency Ablation for the Treatment of Sacroiliac Joint Pain? Results of the COBRA-SIJ study, a Double-blinded, Randomized, Comparative Trial, 2021.
- Lee et al. Latest Evidence Based Application for Radiofrequency Neurotomy. Journal of Pain Research, 2021
- Loh E, Burnham R, et al. Ultrasound-Guided Radiofrequency Ablation for SI Joint Pain. Interventional Pain Medicine, 2022.